Repro-Med Systems net revenue increases 30% for fiscal year ending February 28, 2011

Repro-Med Systems, Inc., (Pink Sheets: REPR) dba RMS Medical Products, today announced unaudited financial results for its fiscal year ended February 28, 2011, showing increases in both domestic and international sales.

The medical devices company is the manufacturer of the FREEDOM60® Syringe Infusion System and the RES-Q-VAC® emergency hand held suction system.  The company also produces expendables used in conjunction with those devices.

Andrew Sealfon, President and CEO of Repro-Med Systems, Inc., stated, "This is the strongest year since inception, with more than $4.9 million in sales revenue.  In addition, the fourth quarter of fiscal year 2011 saw revenues in excess of $1.6 million and continues our positive progress for the fourth, consecutive year."

Financial highlights for the fiscal year ending February 28, 2011 include:

• Overall Net Revenue increased by 30%;
• FREEDOM60® Syringe Infusion System overall product line revenue increased by 38%;
• FREEDOM60® Syringe Infusion System international revenue increased by 83%;
• Strongest sales quarter (fourth quarter ending February 28, 2011) and year in the company's 30-year history.

Mr. Sealfon noted, "We are pleased with the progress we have made in the past year and are looking for continued growth for the coming year, especially with new subcutaneous medications reaching the market served by our FREEDOM60®."